Cited by 168Genetic Neurodegenerative DiseasesDementia and Cognitive Impairment ResearchHealth Systems, Economic Evaluations, Quality of Life

The DOI matches its Crossref record; 283 of the 290 references it cites were found in a registry or an index.

A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases

Open access

Paulsen, Jane S., Nance, Martha, Kim, Ji-In, Carlozzi, Noelle E., Panegyres, Peter K., Erwin, Cheryl, Goh, Anita, McCusker, Elizabeth, Williams, Janet K.·2013·Progress in Neurobiology

DOI 10.1016/j.pneurobio.2013.08.003PMC PMC3833259

Open this paper in CoChat — free account

Abstract

The past decade has witnessed an explosion of evidence suggesting that many neurodegenerative diseases can be detected years, if not decades, earlier than previously thought. To date, these scientific advances have not provoked any parallel translational or clinical improvements. There is an urgency to capitalize on this momentum so earlier detection of disease can be more readily translated into improved health-related quality of life for families at risk for, or suffering with, neurodegenerative diseases. In this review, we discuss health-related quality of life (HRQOL) measurement in neurodegenerative diseases and the importance of these "patient reported outcomes" for all clinical research. Next, we address HRQOL following early identification or predictive genetic testing in some neurodegenerative diseases: Huntington disease, Alzheimer's disease, Parkinson's disease, Dementia with Lewy bodies, frontotemporal dementia, amyotrophic lateral sclerosis, prion diseases, hereditary ataxias, Dentatorubral-pallidoluysian atrophy and Wilson's disease. After a brief report of available direct-to-consumer genetic tests, we address the juxtaposition of earlier disease identification with assumed reluctance toward predictive genetic testing. Forty-one studies examining health-related outcomes following predictive genetic testing for neurodegenerative disease suggested that (a) extreme or catastrophic outcomes are rare; (b) consequences commonly include transiently increased anxiety and/or depression; (c) most participants report no regret; (d) many persons report extensive benefits to receiving genetic information; and (e) stigmatization and discrimination for genetic diseases are poorly understood and policy and laws are needed. Caution is appropriate for earlier identification of neurodegenerative diseases but findings suggest further progress is safe, feasible and likely to advance clinical care.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.pneurobio.2013.08.003

Cites

283 of 283 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Principles of Biomedical Ethics
(2012) · Thieves of Virtue · doi:10.7551/mitpress/9079.003.0009 · Cited by 13,453
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008
Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.011 · Cited by 5,128
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The Sickness Impact Profile: Development and Final Revision of a Health Status Measure
Bergner, M., Bobbitt, R. A., Carter, W. B., & Gilson, B. S. (1981) · Medical Care · doi:10.1097/00005650-198108000-00001 · Cited by 4,619
Classificação Internacional de Funcionalidade (CIF)
Battistella, L. R., & de Brito, C. M. M. (2002) · Acta Fisiátrica · doi:10.5935/0104-7795.20020003 · Cited by 4,470
Untitled work
(1994) · Medical Entomology and Zoology · Cited by 4,156
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Self-citation
The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap Cooperative Group During its First Two Years
Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., Ader, D., Fries, J. F., Bruce, B., & Rose, M. (2007) · Medical Care · doi:10.1097/01.mlr.0000258615.42478.55 · Cited by 3,118
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J. M., Kasarskis, E. J., Munsat, T. L., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,624
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,544
Understanding Disability: From Theory to Practice
OLIVER, M. J. (1995) · Cited by 2,347
A polymorphic DNA marker genetically linked to Huntington's disease
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K. A., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,340
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
The Quality of American Life: Perceptions, Evaluations, and Satisfactions.
Boguslaw, R., Campbell, A., Converse, P. E., & Rodgers, W. L. (1977) · Social Forces · doi:10.2307/2577440 · Cited by 1,947
Cognition and anatomy in three variants of primary progressive aphasia
Gorno‐Tempini, M. L., Dronkers, N. F., Rankin, K. P., Ogar, J. M., Phengrasamy, L., Rosen, H. J., Johnson, J. K., Weiner, M. W., & Miller, B. L. (2004) · Annals of Neurology · doi:10.1002/ana.10825 · Cited by 1,657
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1
Orr, H. T., Chung, M.-Y., Banfi, S., Kwiatkowski, T. J., Servadio, A., Beaudet, A. L., McCall, A. E., Duvick, L. A., Ranum, L. P. W., & Zoghbi, H. Y. (1993) · Nature Genetics · doi:10.1038/ng0793-221 · Cited by 1,632
The International Classification of Functioning, Disability and Health (ICF)
Bickenbach, J. E., & Jerosch‐Herold, C. (2009) · UEA Digital Repository (University of East Anglia) · Cited by 1,600
Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219
Untitled work
(1995) · Cited by 1,191
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration
Cairns, N. J., Bigio, E. H., Mackenzie, I. R. A., Neumann, M., Lee, V. M.-Y., Hatanpaa, K. J., White, C. L., Schneider, J. A., Grinberg, L. T., Halliday, G., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0237-2 · Cited by 1,110
The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study
Chaudhuri, К. R., Martínez‐Martín, P., Brown, R. G., Sethi, K. D., Stocchi, F., Odin, P., Ondo, W. G., Abe, K., Macphee, G. J. A., MacMahon, D., et al. (2007) · Movement Disorders · doi:10.1002/mds.21596 · Cited by 1,090
Whatever does not kill us: cumulative lifetime adversity, vulnerability, and resilience
Seery, M. D., Holman, E. A., & Silver, R. C. (2010) · Journal of Personality and Social Psychology · doi:10.1037/a0021344 · Cited by 954
PRINCIPLES OF BIOMEDICAL ETHICS
Iserson, K. V. (1999) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(05)70060-2 · Cited by 949
Sample size and item calibration stability
Linacre, J. M. (1994) · Medical Entomology and Zoology · Cited by 888
A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length
Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S., Hayden, M. R., & on behalf of an International Huntington's Disease Collaborative Group (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00241.x · Cited by 820
Self-citation
Detection of Huntington's disease decades before diagnosis: the Predict-HD study
Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., NANCE, M. A., Guttman, M., Johnson, S., MacDonald, M. E., Beglinger, L. J., et al. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.128728 · Cited by 808
Self-citation
Neuro-QOL
Cella, D. F., Lai, J., Nowinski, C. J., Victorson, D. E., Peterman, A. H., Miller, D. M., Béthoux, F., Heinemann, A. W., Rubin, S., Cavazos, J. E., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318258f744 · Cited by 789
Multivariate Analysis: The Need for Data, and other Problems
Everitt, B. J. (1975) · The British Journal of Psychiatry · doi:10.1192/bjp.126.3.237 · Cited by 779
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Bertram, L., & Tanzi, R. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2494 · Cited by 747
The overlap of amyotrophic lateral sclerosis and frontotemporal dementia
Lomen, C. E., Anderson, T. T., & Miller, B. L. (2002) · Neurology · doi:10.1212/wnl.59.7.1077 · Cited by 699
The genetic epidemiology of neurodegenerative disease
Bertram, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24761 · Cited by 680
CAG repeat number governs the development rate of pathology in Huntington's disease
Penney, J. B., Vonsattel, J., MacDonald, M. E., Gusella, J. F., & Myers, R. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410521 · Cited by 670
TDP‐43 A315T mutation in familial motor neuron disease
Gitcho, M. A., Baloh, R. H., Chakraverty, S., Mayo, K., Norton, J. B., Levitch, D., Hatanpaa, K. J., White, C. L., Bigio, E. H., Caselli, R. J., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21344 · Cited by 633
Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease
Postuma, R. B., Aarsland, D., Barone, P., Burn, D. J., Hawkes, C. H., Oertel, W. H., & Ziemssen, T. (2012) · Movement Disorders · doi:10.1002/mds.24996 · Cited by 615
The link between the GBA gene and parkinsonism
Sidransky, E., & Lopez, G. J. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70190-4 · Cited by 610
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
Tabrizi, S. J., Scahill, R. I., Dürr, A., Roos, R. A. C., Leavitt, B. R., Jones, R., Landwehrmeyer, G. B., Fox, N. C., Johnson, H. J., Hicks, S. L., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70276-3 · Cited by 597
Disclosure of APOE Genotype for Risk of Alzheimer's Disease
Green, R. C., Roberts, J. S., Cupples, L. A., Relkin, N. R., Whitehouse, P. J., Brown, T., Eckert, S. L., Butson, M., Sadovnick, A. D., Quaid, K. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809578 · Cited by 554
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study
Reiman, E. M., Quiroz, Y. T., Fleisher, A. S., Chen, K., Velez-Pardo, C., Jimenez-Del-Rio, M., Fagan, A. M., Shah, A. R., Alvarez, S., Arbelaez, A., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70228-4 · Cited by 541
The heritability and genetics of frontotemporal lobar degeneration
Rohrer, J. D., Guerreiro, R., Vandrovcova, J., Uphill, J., Reiman, D., Beck, J., Isaacs, A. M., Authier, A., Ferrari, R., Fox, N. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bf997a · Cited by 536
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease
Nichols, W. C., Pankratz, N., Hernandez, D., Paisán-Ruíz, C., Jain, S., Halter, C. A., Michaels, V. E., Reed, T., Rudolph, A., Shults, C. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17828-3 · Cited by 457
The Psychological Consequences of Predictive Testing for Huntington’s Disease
Wiggins, S., Whyte, P., Huggins, M. J., Adam, S., Theilmann, J., Bloch, M., Sheps, S. B., Schechter, M. T., Hayden, M. R., & Testing*, T. C. C. S. O. P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272001 · Cited by 456
Technical report: ethical and policy issues in genetic testing and screening of children
Ross, L. F., Saal, H. M., David, K. L., & Anderson, R. R. (2013) · Genetics in Medicine · doi:10.1038/gim.2012.176 · Cited by 455
Genomewide association study for susceptibility genes contributing to familial Parkinson disease
Pankratz, N., Wilk, J. B., Latourelle, J. C., DeStefano, A. L., Halter, C. A., Pugh, E., Doheny, K. F., Gusella, J. F., Nichols, W. C., Foroud, T., et al. (2008) · Human Genetics · doi:10.1007/s00439-008-0582-9 · Cited by 445
The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size.
Brinkman, R. R., Mezei, M., Theilmann, J., Almqvist, E. W., & Hayden, M. R. (1997) · Europe PMC (PubMed Central) · Cited by 368
Environmental Enrichment Rescues Protein Deficits in a Mouse Model of Huntington's Disease, Indicating a Possible Disease Mechanism
Spires‐Jones, T. L., Grote, H., Varshney, N. K., Cordery, P. M., van Dellen, A., Blakemore, C. B., & Hannan, A. J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1658-03.2004 · Cited by 367
Cognitive Impairment in Huntington Disease: Diagnosis and Treatment
Paulsen, J. S. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0215-x · Cited by 364
Self-citation
Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing
Gershon, R. C., Lai, J. S., Bode, R. K., Choi, S. W., Moy, C. S., Bleck, T., Miller, D. M., Peterman, A. H., & Cella, D. F. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9958-8 · Cited by 361
The genetic testing of children. Working Party of the Clinical Genetics Society (UK)
Clarke, A. J. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.10.785 · Cited by 357
CAG‐repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches
Langbehn, D. R., Hayden, M. R., Paulsen, J. S., & and the PREDICT‐HD Investigators of the Huntington Study Group (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30992 · Cited by 338
Self-citation
Environmental enrichment slows disease progression in R6/2 Huntington's disease mice
Hockly, E., Cordery, P. M., Woodman, B., Mahal, A., van Dellen, A., Blakemore, C. B., Lewis, C. M., Hannan, A. J., & Bates, G. P. (2002) · Annals of Neurology · doi:10.1002/ana.10094 · Cited by 336
Proteolysis of Mutant Huntingtin Produces an Exon 1 Fragment That Accumulates as an Aggregated Protein in Neuronal Nuclei in Huntington Disease
Landles, C., Sathasivam, K., Weiss, A., Woodman, B., Moffitt, H., Finkbeiner, S. M., Sun, B., Gafni, J., Ellerby, L., Trottier, Y., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.075028 · Cited by 328
Genetic Discrimination: Perspectives of Consumers
Lapham, E. V., Kozma, C., & Weiss, J. O. (1996) · Science · doi:10.1126/science.274.5287.621 · Cited by 318
Genetics of Parkinson's disease and parkinsonism
Hardy, J., Cai, H., Cookson, M., Gwinn, K. A., & Singleton, A. (2006) · Annals of Neurology · doi:10.1002/ana.21022 · Cited by 312
Guidelines for the molecular genetics predictive test in Huntington's disease
(1994) · Neurology · doi:10.1212/wnl.44.8.1533 · Cited by 310
Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: A prospective study
Postuma, R. B., Bertrand, J., Montplaisir, J. Y., Desjardins, C., Vendette, M., Romenets, S. R., Panisset, M., & Gagnon, J. (2012) · Movement Disorders · doi:10.1002/mds.24939 · Cited by 307
Ethical Principles and Guidelines for the Protection of Human Subjects of Research.
(1979) · PsycEXTRA Dataset · doi:10.1037/e301872003-001 · Cited by 295
Pathological correlates of gastrointestinal dysfunction in Parkinson's disease
Cersosimo, M. G., & Benarroch, E. E. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.014 · Cited by 294
A Worldwide Assessment of the Frequency of Suicide, Suicide Attempts, or Psychiatric Hospitalization after Predictive Testing for Huntington Disease
Almqvist, E. W., Bloch, M., Brinkman, R. R., Craufurd, D., & Hayden, M. R. (1999) · The American Journal of Human Genetics · doi:10.1086/302374 · Cited by 287
The Relationship of 60 Disease Diagnoses and 15 Conditions to Preference-Based Health-Related Quality of Life in Ontario Hospital-Based Long-Term Care Residents
Lam, J. M. C., & Wodchis, W. P. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181ca2647 · Cited by 272
Statement on Use of Apolipoprotein E Testing for Alzheimer Disease
Farrer, L. A. (1995) · JAMA · doi:10.1001/jama.1995.03530200063039 · Cited by 271
Patient Autonomy and Incidental Findings in Clinical Genomics
Wolf, S. M., Annas, G. J., & Elias, S. (2013) · Science · doi:10.1126/science.1239119 · Cited by 269
US Biomedical Research
Zerhouni, E. A. (2005) · JAMA · doi:10.1001/jama.294.11.1352 · Cited by 256
The differential mediating effects of pain and depression on the physical and mental dimension of quality of life in Hong Kong Chinese adults
Wong, W. S., Chan, T. M. S., Fung, V. B., & Fielding, R. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-1 · Cited by 256
[Measuring quality of life in palliative care].
Ferreira, P. L., Barros, A. P., & Brito, A. B. (2008) · PubMed · Cited by 254
Longitudinal change in regional brain volumes in prodromal Huntington disease
Aylward, E., Nopoulos, P., Ross, C. A., Langbehn, D. R., Pierson, R. K., Mills, J. A., Johnson, H. J., Magnotta, V. A., Juhl, A. R., Paulsen, J. S., et al. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.208264 · Cited by 253
Self-citation
Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers
Borry, P., Stultiëns, L., Nys, H., Cassiman, J.-J., & Dierickx, K. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00692.x · Cited by 251
The complexities of predictive genetic testing
Evans, J. P., Skrzynia, C., & Burke, W. (2001) · British medical journal · doi:10.1136/bmj.322.7293.1052 · Cited by 247
Health Behavior Changes After Genetic Risk Assessment for Alzheimer Disease: The REVEAL Study
Chao, S. H.-L., Roberts, J. S., Marteau, T. M., Silliman, R. A., Cupples, L. A., & Green, R. C. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815a9dcc · Cited by 243
Psychological impact of genetic testing for Huntington's disease: an update of the literature
Meiser, B. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.5.574 · Cited by 243
Apolipoprotein E genotyping in Alzheimer's disease
Relkin, N. R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90284-6 · Cited by 239
The meaning of illness: a phenomenological approach to the patient-physician relationship.
Toombs, S. (1987) · Journal of Medicine and Philosophy · doi:10.1093/jmp/12.3.219 · Cited by 238
Recommendations for the predictive genetic test in Huntington's disease
MacLeod, R., Tibben, A., Frontali, M., Evers‐Kiebooms, G., Jones, A., Martínez‐Descals, A., & Roos, R. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01900.x · Cited by 237
Brain Structure in Preclinical Huntington’s Disease
Paulsen, J. S., Magnotta, V. A., Mikos, A., Paulson, H. L., Penziner, E., Andreasen, N. C., & Nopoulos, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.003 · Cited by 236
Self-citation
Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE
Wijsman, E. M., Pankratz, N., Choi, Y., Rothstein, J. H., Faber, K. M., Cheng, R., Lee, J. H., Bird, T. D., Bennett, D. A., Diaz-Arrastia, R. R., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001308 · Cited by 229
Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey
Bombard, Y., Veenstra, G., Friedman, J. M., Creighton, S., Currie, L., Paulsen, J. S., Bottorff, J. L., & Hayden, M. R. (2009) · BMJ · doi:10.1136/bmj.b2175 · Cited by 221
Self-citation
UPTAKE OF PRESYMPTOMATIC PREDICTIVE TESTING FOR HUNTINGTON'S DISEASE
Craufurd, D., Kerzin-Storrar, L., Dodge, A., & Harris, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90722-8 · Cited by 218
Sources of Structure: Genetic, Environmental, and Artifactual Influences on the Covariation of Personality Traits
McCrae, R. R., Jang, K. L., Livesley, W. J., Riemann, R., & Angleitner, A. (2001) · Journal of Personality · doi:10.1111/1467-6494.694154 · Cited by 214
Molecular-clinical correlations in males with an expanded FMR1 mutation
Merenstein, S. A., Sobesky, W. E., Taylor, A. K., Riddle, J. E., Tran, H. X., & Hagerman, R. J. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960809)64:2 · Cited by 213
Reluctance to undergo predictive testing: The case of Huntington Disease
Quaid, K. A., & Morris, M. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320450112 · Cited by 210
The Neurology Quality-of-Life Measurement Initiative
Cella, D. F., Nowinski, C. J., Peterman, A. H., Victorson, D. E., Miller, D. M., Lai, J., & Moy, C. S. (2011) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2011.01.025 · Cited by 207
The Genetic Information Nondiscrimination Act of 2008
Donald, C. G., & Sanders, A. K. (2008) · Journal of Diversity Management (JDM) · doi:10.19030/jdm.v3i4.5000 · Cited by 205
Clinical markers of early disease in persons near onset of Huntington’s disease
Paulsen, J. S., Zhao, H., Stout, J. C., Brinkman, R. R., Guttman, M., Ross, C. A., Como, P. G., Manning, C. A., Hayden, M. R., Shoulson, I., et al. (2001) · Neurology · doi:10.1212/wnl.57.4.658 · Cited by 204
Self-citation
The Clinical Introduction of Genetic Testing for Alzheimer Disease An Ethical Perspective
Post, S. G. (1997) · JAMA · doi:10.1001/jama.277.10.832 · Cited by 204
International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease.
(1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.7.555 · Cited by 204
Thalamic metabolism and symptom onset in preclinical Huntington's disease
Feigin, A., Tang, C., Ma, Y., Mattis, P. J., Zgaljardic, D. J., Guttman, M., Paulsen, J. S., DHAWAN, V. M., & Eidelberg, D. (2007) · Brain · doi:10.1093/brain/awm217 · Cited by 198
Self-citation
Measuring quality of life in palliative care.
Cella, D. F. (1995) · PubMed · Cited by 196
Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease
Johnson, H. J., Stout, J. C., Solomon, A. C., Langbehn, D. R., Aylward, E., Cruce, C. B., Ross, C. A., NANCE, M. A., Kayson, E., Julian-Baros, E., et al. (2007) · Brain · doi:10.1093/brain/awm107 · Cited by 195
Self-citation
Attitudes of persons at risk for Huntington disease toward predictive testing
Kessler, S., Field, T., Worth, L. L., Mosbarger, H., Opitz, J. M., & Reynolds, J. F. (1987) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320260204 · Cited by 194
Quality of Life in Rare Genetic Conditions: A Systematic Review of the Literature
Cohen, J., & Biesecker, B. B. (2010) · American Journal of Medical Genetics. Part A · doi:10.1002/ajmg.a.33380 · Cited by 193
Behavioural abnormalities contribute to functional decline in Huntington's disease
Hamilton, J. M. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.1.120 · Cited by 191
The influence of cognitive impairment on health-related quality of life in neurological disease
Mitchell, A. J., Kemp, S., Benito‐León, J., & Reuber, M. (2010) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2009.00439.x · Cited by 185
Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment
Lazic, S. E., Grote, H., Blakemore, C. B., Hannan, A. J., van Dellen, A., Phillips, W., & Barker, R. A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04715.x · Cited by 184
Genetics and Epigenetics of Parkinson's Disease
Coppedè, F. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/489830 · Cited by 182
Psychological costs and benefits of predictive testing for Huntington's disease
Codori, A., & Brandt, J. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320540304 · Cited by 179
Ethics and Genomic Incidental Findings
McGuire, A. L., Joffe, S., Koenig, B. A., Biesecker, B. B., McCullough, L. B., Blumenthal‐Barby, J. S., Caulfield, T., Terry, S. F., & Green, R. C. (2013) · Science · doi:10.1126/science.1240156 · Cited by 172
Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease
Labbadia, J. P., Cunliffe, H. E., Weiss, A., Katsyuba, E., Sathasivam, K., Seredenina, T. S., Woodman, B., Moussaoui, S. M., Frentzel, S., Luthi‐Carter, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57413 · Cited by 172
Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics
Recommendations of the European Society of Human Genetics (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.26 · Cited by 167
Attitudes toward presymptomatic testing in Huntington disease
Mastromauro, C. A., Myers, R. H., Berkman, B., Opitz, J. M., & Reynolds, J. F. (1987) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320260205 · Cited by 167
Predictive testing for Huntington disease in Canada: The experience of those receiving an increased risk
Bloch, M., Adam, S., Wiggins, S., Huggins, M. J., & Hayden, M. R. (1992) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320420416 · Cited by 164
Genetic Information Nondiscrimination Act
Funke, R. D., Dillard, B., Potthast, A., Boxall, S. F., Carr, E., Carr, S., Diaz-Sprague, R., Elliott, D. L., England, R., & Price, C. (2008) · Ethics & Behavior · Cited by 161
Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease
Aziz, N. A., Anguelova, G. V., Marinus, J., Lammers, G. J., & Roos, R. A. C. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.009 · Cited by 155
Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners.
Tibben, A., Timman, R., Bannink, E. C., & Duivenvoorden, H. J. (1997) · Health Psychology · doi:10.1037//0278-6133.16.1.20 · Cited by 151
Health‐related quality of life in Huntington's disease: Which factors matter most?
Ho, A. K., Gilbert, A. S., Mason, S., Goodman, A. O., & Barker, R. A. (2008) · Movement Disorders · doi:10.1002/mds.22412 · Cited by 150
Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT‐HD study
Biglan, K., Ross, C. A., Langbehn, D. R., Aylward, E., Stout, J. C., Queller, S., Carlozzi, N. E., Duff, K., Beglinger, L. J., & Paulsen, J. S. (2009) · Movement Disorders · doi:10.1002/mds.22601 · Cited by 146
Self-citation
Differential item functioning (DIF) analyses of health-related quality of life instruments using logistic regression
the EORTC Quality of Life Group and the Quality of Life Cross-Cultural Meta-Analysis Group, SCOTT, N. W., Fayers, P. M., Aaronson, N. K., Bottomley, A., de Graeff, A., Grøenvold, M., Gundy, C. M., Koller, M. T., Petersen, M. A., et al. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-81 · Cited by 146
Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology.
Went, L. N. (1990) · Journal of Medical Genetics · doi:10.1136/jmg.27.1.34 · Cited by 143
Development and validation of the positive affect and well-being scale for the neurology quality of life (Neuro-QOL) measurement system
Salsman, J. M., Victorson, D. E., Choi, S. W., Peterman, A. H., Heinemann, A. W., Nowinski, C. J., & Cella, D. F. (2013) · Quality of Life Research · doi:10.1007/s11136-013-0382-0 · Cited by 141
Willingness‐to‐pay for predictive tests with no immediate treatment implications: a survey of US residents
Neumann, P. J., Cohen, J. T., Hammitt, J. K., Concannon, T. W., Auerbach, H. R., Fang, C., & Kent, D. M. (2010) · Health Economics · doi:10.1002/hec.1704 · Cited by 141
Predictive testing for Huntington's disease
Tibben, A. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.10.023 · Cited by 140
The Multiple Faces of Valosin-Containing Protein-Associated Diseases: Inclusion Body Myopathy with Paget’s Disease of Bone, Frontotemporal Dementia, and Amyotrophic Lateral Sclerosis
Nalbandian, A., Donkervoort, S. C., Dec, E., Badadani, M., Katheria, V., Rana, P., Nguyen, C. C., Mukherjee, J., Caiozzo, V. J., Martin, B., et al. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9627-y · Cited by 140
Delayed onset of huntington′s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors
Glass, M., van Dellen, A., Blakemore, C. B., Hannan, A. J., & Faull, R. L. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00595-5 · Cited by 138
Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease
Djoussé, L., Knowlton, B., Hayden, M., Almqvist, E. W., Brinkman, R., Ross, C., Margolis, R., Rosenblatt, A., Durr, A., Dode, C., et al. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20190 · Cited by 135
Self-citation
Predictive testing for Huntington disease: interpretation and significance of intermediate alleles
Semaka, A., Creighton, S., Warby, S. C., & Hayden, M. R. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00668.x · Cited by 133
The chromosome 9 ALS and FTD locus is probably derived from a single founder
Mok, K., Traynor, B. J., Schymick, J., Tienari, P. J., Laaksovirta, H., Peuralinna, T., Myllykangas, L., Chiò, A., Shatunov, A., Boeve, B. F., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.005 · Cited by 131
Genetics of Parkinson disease
Pankratz, N., & Foroud, T. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31815bf97c · Cited by 129
Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease
Almqvist, E. W., Brinkman, R. R., Wiggins, S., Hayden, M. R., & Testing, T. C. C. S. O. P. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00157.x · Cited by 125
At‐risk Persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan
Markel, D. S., Young, A. B., Penney, J. B., Opitz, J. M., & Reynolds, J. F. (1987) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320260207 · Cited by 122
Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.
Decruyenaere, M., Evers‐Kiebooms, G., Boogaerts, A., Cassiman, J. J., Cloostermans, T., Demyttenaere, K., Dom, R., Fryns, J. P., & BERGHE, H. V. D. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.9.737 · Cited by 120
Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners.
Tibben, A., Timman, R., Bannink, E. C., et al. (1997) · Health Psychology · doi:10.1037/0278-6133.16.1.20 · Cited by 118
Psychological distress in the 5-year period after predictive testing for Huntington's disease
Decruyenaere, M., Evers‐Kiebooms, G., Cloostermans, T., Boogaerts, A., Demyttenaere, K., Dom, R., & Fryns, J. P. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200913 · Cited by 117
Who seeks genetic susceptibility testing for Alzheimer’s disease? Findings from a multisite, randomized clinical trial
Roberts, J. S., Barber, M., Brown, T., Cupples, L. A., Farrer, L. A., LaRusse, S., Post, S. G., Quaid, K. A., Ravdin, L., Relkin, N. R., et al. (2004) · Genetics in Medicine · doi:10.1097/01.gim.0000132688.55591.77 · Cited by 113
Adverse Effects of Predictive Testing for Huntington Disease Underestimated: Long-Term Effects 7-10 Years After the Test.
Timman, R., Roos, R. A. C., Maat‐Kievit, A., & Tibben, A. (2004) · Health Psychology · doi:10.1037/0278-6133.23.2.189 · Cited by 113
Long-term outcome of presymptomatic testing in Huntington disease
Gargiulo, M., Lejeune, S., Tanguy, M., Lahlou‐Laforêt, K., Faudet, A., Cohen, D., Feingold, J., & Dürr, A. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.146 · Cited by 113
Carrier testing in minors: a systematic review of guidelines and position papers
Borry, P., Fryns, J., Schotsmans, P. T., & Dierickx, K. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201509 · Cited by 112
The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: implications for multidisciplinary counselling and for genetic education
Evers‐Kiebooms, G., Welkenhuysen, M., Claes, E., Decruyenaere, M., & Denayer, L. (2000) · Social Science & Medicine · doi:10.1016/s0277-9536(00)00064-2 · Cited by 111
Functional imaging in Huntington's disease
Paulsen, J. S. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.12.015 · Cited by 109
Self-citation
On attitudes and appreciation 6 months after predictive DNA testing for huntington disease in the Dutch program
Tibben, A., Frets, P. G., van de Kamp, J. J. P., Niermeijer, M. F., der Vlis, M. V.-V., Roos, R. A. C., Rooymans, H. G. M., van Ommen, G. B., & Verhage, F. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320480209 · Cited by 108
To know or not to know: A review of behaviour and suicidal ideation in preclinical Huntington's disease
Wahlin, T. R. (2006) · Patient Education and Counseling · doi:10.1016/j.pec.2006.08.009 · Cited by 108
Impact of DNA Testing for Early-Onset Familial Alzheimer Disease and Frontotemporal Dementia
Steinbart, E. J. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1828 · Cited by 107
Concerns in a primary care population about genetic discrimination by insurers
Hall, M. A., McEwen, J. E., Barton, J. C., Walker, A. P., Howe, E. G., Reiss, J. A., Power, T. E., Ellis, S. D., Tucker, D. C., Harrison, B. W., et al. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000162874.58370.c0 · Cited by 106
Clinical prediction of Parkinson's disease: planning for the age of neuroprotection
Postuma, R. B., Gagnon, J., & Montplaisir, J. Y. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.174748 · Cited by 106
Wilson disease—A practical approach to diagnosis, treatment and follow-up
Medici, V., Rossaro, L., & Sturniolo, G. C. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.12.095 · Cited by 100
International Literature Review on WHODAS II (World Health Organization Disability Assessment Schedule II)
Federici, S., Meloni, F., & Lo Presti, A. (2009) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 100
Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease
Farrer, L. A., Brin, M. F., Elsas, L. J., Goate, A., Kennedy, J. L., Mayeux, R. P., Myers, R. H., Reilly, P. M., & RISCH, N. J. (1995) · JAMA · doi:10.1001/jama.274.20.1627 · Cited by 100
Presymptomatic DNA‐testing for Huntington disease: Pretest attitudes and expectations of applicants and their partners in the Dutch program
Tibben, A., Frets, P. G., van de Kamp, J. J. P., Niermeijer, M. F., der Vlis, M. V.-V., Roos, R. A. C., van Ommen, G. B., Duivenvoorden, H. J., & Verhage, F. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320480105 · Cited by 96
Predictors of psychological adjustment to genetic testing for Huntington's disease.
Codori, A., Slavney, P. R., Young, C., Miglioretti, D. L., & Brandt, J. (1997) · Health Psychology · doi:10.1037/0278-6133.16.1.36 · Cited by 94
Early detection of Huntington‘s disease
Paulsen, J. S. (2009) · Future Neurology · doi:10.2217/fnl.09.78 · Cited by 93
Self-citation
Presymptomatic DNA testing for Huntington disease: Identifying the need for psychological intervention
Tibben, A., Duivenvoorden, H. J., der Vlis, M. V.-V., Niermeijer, M. F., Frets, P. G., van de Kamp, J. J. P., Roos, R. A. C., Rooijmans, H. G. M., & Verhage, F. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320480305 · Cited by 91
Daytime somnolence and nocturnal sleep disturbances in Huntington disease
Videnović, A., Leurgans, S. E., Fan, W., Jaglin, J., & Shannon, K. M. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.10.002 · Cited by 90
Application of the National Institutes of Health Patient-reported Outcome Measurement Information System (PROMIS) to mental health research.
Riley, W. T., Pilkonis, P. A., & Cella, D. F. (2011) · PubMed · Cited by 89
Self-paced timing detects and tracks change in prodromal Huntington disease.
Rowe, K. C., PREDICT-HD Investigators of the Huntington Study Group, Paulsen, J. S., Langbehn, D. R., Duff, K., Beglinger, L. J., Wang, C., O’Rourke, J. J. F., Stout, J. C., & Moser, D. J. (2010) · Neuropsychology · doi:10.1037/a0018905 · Cited by 88
Self-citation
Investigating genetic discrimination in Australia: a large‐scale survey of clinical genetics clients
Taylor, S. D., Treloar, S. A., Barlow-Stewart, K. K., Stranger, M., & Otlowski, M. F. A. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01016.x · Cited by 86
Guidelines for the Ethical, Social and Legal Issues in Prenatal Diagnosis
Powledge, T. M., & Fletcher, J. C. (1979) · New England Journal of Medicine · doi:10.1056/nejm197901253000404 · Cited by 86
Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice
Schilling, G., Savonenko, A. V., Coonfield, M. L., Morton, J. L., Vorovich, E. B., Gale, A., Neslon, C., Chan, N., Eaton, M., Fromholt, D., et al. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.003 · Cited by 85
Attitudes of subjects at risk and their relatives towards genetic counselling in Huntington's chorea.
Tyler, A., & Harper, P. S. (1983) · Journal of Medical Genetics · doi:10.1136/jmg.20.3.179 · Cited by 84
Recent Advances in the Genetics of Cerebellar Ataxias
Sailer, A., & Houlden, H. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0267-6 · Cited by 83
Refining the diagnosis of Huntington disease: the PREDICT-HD study
Biglan, K. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00012 · Cited by 83
Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP
Mead, S., Uphill, J. B., Beck, J., Poulter, M., Campbell, T., Lowe, J., Adamson, G., Hummerich, H., Klopp, N., Rückert, I., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr607 · Cited by 83
Clinical and Pathological Overlap between Frontotemporal Dementia, Primary Progressive Aphasia and Corticobasal Degeneration: The Pick Complex
KERTESZ, A. E., Davidson, W., & Muñoz, D. G. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051212 · Cited by 82
An international survey of predictive genetic testing in children for adult onset conditions
Duncan, R. E., Savulescu, J., Gillam, L. H., Williamson, R., & Delatycki, M. B. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000170775.39092.44 · Cited by 81
A de novo missense mutation of the FUS gene in a “true” sporadic ALS case
Chiò, A., Calvo, A., Moglia, C., Ossola, I., Brunetti, M., Sbaiz, L., Lai, S.-L., Abramzon, Y. A., Traynor, B. J., & Restagno, G. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.016 · Cited by 81
Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients
Apse, K. A., Biesecker, B. B., Giardiello, F. M., Fuller, B. P., & Bernhardt, B. A. (2004) · Genetics in Medicine · doi:10.1097/01.gim.0000144013.96456.6c · Cited by 78
An algorithm for genetic testing of frontotemporal lobar degeneration
Goldman, J. S., Rademakers, R., Huey, E. D., Boxer, A. L., Mayeux, R. P., Miller, B. L., & Boeve, B. F. (2011) · Neurology · doi:10.1212/wnl.0b013e31820a0d13 · Cited by 78
Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease
Carlozzi, N. E., & Tulsky, D. S. (2012) · Journal of Health Psychology · doi:10.1177/1359105312438109 · Cited by 77
Self-citation
A Comparison of Mood and Quality of Life Among People with Progressive Neurological Illnesses and Their Caregivers
McCabe, M. P., Firth, L., & O’Connor, E. (2009) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-009-9168-5 · Cited by 76
Genetic risk of Alzheimer's disease: advising relatives
Liddell, M. B., Lovestone, S., & Owen, M. J. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.1.7 · Cited by 75
Experience over fifteen years with a protocol for predictive testing for Huntington disease
Dufrasne, S., Roy, M., Gálvez, M. C. C., & Rosenblatt, D. S. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.12.001 · Cited by 75
Using Focus Groups To Inform the Neuro-QOL Measurement Tool: Exploring Patient-Centered, Health-Related Quality of Life Concepts Across Neurological Conditions
Perez, L. V., Huang, J. C., Jansky, L. J., Nowinski, C. J., Victorson, D. E., Peterman, A. H., & Cella, D. F. (2007) · Journal of Neuroscience Nursing · doi:10.1097/01376517-200712000-00005 · Cited by 74
Postgenomics, uncertain futures, and the familiarization of susceptibility genes
Chilibeck, G., Lock, M. M., & Sehdev, M. (2010) · Social Science & Medicine · doi:10.1016/j.socscimed.2010.01.053 · Cited by 74
Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease
Babul, R. (1993) · JAMA · doi:10.1001/jama.270.19.2321 · Cited by 74
Ethnic differences in the expression of neurodegenerative disease: Machado‐Joseph disease in Africans and Caucasians
Subramony, S. H., Hernandez, D. G., Adam, A., Smith‐Jefferson, S., Hussey, J., Gwinn, K. A., Lynch, T., McDaniel, O. D., Hardy, J., Farrer, M. J., et al. (2002) · Movement Disorders · doi:10.1002/mds.10241 · Cited by 73
Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing.
Lawson, K., Wiggins, S., Green, T., Adam, S., Bloch, M., & Hayden, M. R. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.10.856 · Cited by 72
8OHdG as a marker for Huntington disease progression
Long, J. D., Matson, W. R., Juhl, A. R., Leavitt, B. R., & Paulsen, J. S. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.02.012 · Cited by 71
Self-citation
Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians
Lowstuter, K. J., Sand, S. R., Blazer, K. R., MacDonald, D. J., Banks, K. C., Lee, C. A., Schwerin, B. U., Juarez, M., Uman, G. C., & Weitzel, J. N. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e3181837246 · Cited by 69
Why test children for adult-onset genetic diseases?
Rhodes, R. (2006) · PubMed · Cited by 68
The motivation of at‐risk individuals and their partners in deciding for or against predictive testing for Huntington's disease
Evers‐Kiebooms, G., Swerts, A., Cassiman, J. J., & BERGHE, H. V. D. (1989) · Clinical Genetics · doi:10.1111/j.1399-0004.1989.tb02902.x · Cited by 68
Predicting Parkinson's disease – why, when, and how?
Postuma, R. B., & Montplaisir, J. Y. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70793-x · Cited by 67
Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea.
(1994) · PubMed · Cited by 67
Impact of Huntington's across the entire disease spectrum: the phases and stages of disease from the patient perspective
Ho, A., Hocaoğlu, M., & for the European Huntington's Disease Network Quality of Life Working Group (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01748.x · Cited by 66
Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease
Bombard, Y., Penziner, E., Suchowersky, O., Guttman, M., Paulsen, J. S., Bottorff, J. L., & Hayden, M. R. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201937 · Cited by 66
Self-citation
Perception, experience, and response to genetic discrimination in Huntington disease: The international RESPOND‐HD study
Erwin, C. J., Williams, J. K., Juhl, A. R., Mengeling, M. A., Mills, J. A., Bombard, Y., Hayden, M. R., Quaid, K. A., Shoulson, I., Taylor, S. D., et al. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31079 · Cited by 66
Self-citation
Decrease in lipid peroxidation measured by breath pentane output in normals after oral supplementation with vitamin E
Gossum, A. V., Kurian, R., Whitwell, J., & Jeejeebhoy, K. N. (1988) · Clinical Nutrition · doi:10.1016/0261-5614(88)90012-x · Cited by 66
Ethical issues policy statement on Huntington's disease molecular genetics predictive test
(1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90243-8 · Cited by 66
Predictors of quality of life in carers for people with a progressive neurological illness: a longitudinal study
O’Connor, E. J., & McCabe, M. P. (2010) · Quality of Life Research · doi:10.1007/s11136-010-9804-4 · Cited by 65
Unstable familial transmissions of Huntington disease alleles with 27–35 CAG repeats (intermediate alleles)
Semaka, A., Collins, J. A., & Hayden, M. R. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30970 · Cited by 65
Health‐related quality of life in Huntington's disease: A comparison of two generic instruments, SF‐36 and SIP
Ho, A. K., Robbins, A. O. G., Walters, S. J., Kaptoge, S. K., Sahakian, B. J., & Barker, R. A. (2004) · Movement Disorders · doi:10.1002/mds.20208 · Cited by 65
A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder
Bogaerts, V., Engelborghs, S., Kumar‐Singh, S., Goossens, D., Pickut, B. A., van der Zee, J., Sleegers, K., Peeters, K., Martin, J., Del‐Favero, J., et al. (2007) · Brain · doi:10.1093/brain/awm167 · Cited by 65
Genetic testing in Parkinson's disease
McInerney-Leo, A. M., Hadley, D. W., Gwinn, K. A., & Hardy, J. (2004) · Movement Disorders · doi:10.1002/mds.20316 · Cited by 64
The Spinocerebellar Ataxias: Clinical Aspects And Molecular Genetics
Matilla‐Dueñas, A., Corral‐Juan, M., Volpini, V., & Sánchez, I. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_27 · Cited by 63
Cognitive and Psychiatric Aspects of Huntington Disease Contribute to Functional Capacity
Nehl, C., & Paulsen, J. S. (2003) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000106004.67587.57 · Cited by 63
Self-citation
Genetic susceptibility testing for neurodegenerative diseases: Ethical and practice issues
Roberts, J. S., & Uhlmann, W. R. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.02.005 · Cited by 62
Biobanks: Importance, Implications and Opportunities for Genetic Counselors
Hawkins, A. K. (2010) · Journal of Genetic Counseling · doi:10.1007/s10897-010-9305-1 · Cited by 60
Genetic Privacy Laws and Patients' Fear of Discrimination by Health Insurers: The View from Genetic Counselors
Hall, M. A., & Rich, S. S. (2000) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.2000.tb00668.x · Cited by 60
Reflexive and volitional saccades: Biomarkers of Huntington disease severity and progression
Patel, S. S., Jankovic, J. J., Hood, A. J., Jeter, C. B., & Sereno, A. B. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.09.035 · Cited by 59
Genetics of Dementia
Paulson, H. L., & Igo, I. S. (2011) · Seminars in Neurology · doi:10.1055/s-0031-1299784 · Cited by 57
Perceptions of discrimination among persons who have undergone predictive testing for Huntington's disease
Penziner, E., Williams, J. K., Erwin, C. J., Bombard, Y., Wallis, A. B., Beglinger, L. J., Hayden, M. R., & Paulsen, J. S. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30600 · Cited by 55
Self-citation
Novel p.Ile151Val mutation in VCP in a patient of African American descent with sporadic ALS
DeJesus-Hernandez, M., Desaro, P., Johnston, A., Ross, O. A., Wszolek, Z. K., Ertekin-Taner, N., Graff-Radford, N. R., Rademakers, R., & Boylan, K. (2011) · Neurology · doi:10.1212/wnl.0b013e31822e563c · Cited by 55
Predictive Genetic Testing for Alzheimer's Disease: Impact upon Risk Perception
Marteau, T. M., Roberts, J. S., LaRusse, S., & Green, R. C. (2005) · Risk Analysis · doi:10.1111/j.1539-6924.2005.00598.x · Cited by 54
Relationship between CAG repeat length and brain volume in premanifest and early Huntington’s disease
Henley, S. M. D., Wild, E. J., Hobbs, N. Z., Scahill, R. I., Ridgway, G. R., MacManus, D. G., Barker, R., Fox, N. C., & Tabrizi, S. J. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0052-x · Cited by 54
In their own words: Reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND‐HD study
Williams, J. K., Erwin, C. J., Juhl, A. R., Mengeling, M. A., Bombard, Y., Hayden, M. R., Quaid, K. A., Shoulson, I., Taylor, S. D., Paulsen, J. S., et al. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31080 · Cited by 54
Self-citation
Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease
Decruyenaere, M., Evers‐Kiebooms, G., Boogaerts, A., Cassiman, J. J., Cloostermans, T., Demyttenaere, K., Dom, R., & Fryns, J. P. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.12.897 · Cited by 52

Research works printed but not linked: 6

Cassidy, 2008, Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease, Alzheimer's Dementia: J. Alzheimer's Assoc., 4, 406, 10.1016/j.jalz.2008.04.007 · DOI
Cella, 2010, The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008, J. Clin. Epidemiol., 63, 1179, 10.1016/j.jclinepi.2010.04.011 · DOI · Paper page
Huntington, 1872, On chorea, Med. Surg. Rep. Phila., 26, 317
Patrick, 1988, What constitutes quality of life?. Concepts and dimensions, Clin. Nutr., 7, 53
Rothstein, 2007, Genetic Information Nondiscirimination Act is a first step; won’t solve the problem, CCH Labor Law Rep., 950
Wahlin, 1998, Reactions to predictive testing in Huntington disease: case reports of coping with a new genetic status, Am. J. Med. Genet., 73, 356, 10.1002/(SICI)1096-8628(19971219)73:3<356::AID-AJMG24>3.0.CO;2-H · DOI

Sorted by citations

Biomarkers of aging
Bao, H., Cao, J., Chen, M., Min, C., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., Chen, Z., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 402
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Lewczuk, P., Riederer, P. F., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramírez, A., Parnetti, L., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1375556 · Cited by 318
Depression in neurodegenerative diseases: Common mechanisms and current treatment options
Galts, C., Bettio, L. E. B., Jewett, D. C., Yang, C. C., Brocardo, P. S., Rodrigues, A. L. S., Thacker, J. S., & Gil‐Mohapel, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.002 · Cited by 278
Multi-modality machine learning predicting Parkinson’s disease
Makarious, M. B., Leonard, H. L., Vitale, D., Iwaki, H., Sargent, L. J., Dadu, A., Violich, I., Hutchins, E. D., Saffo, D., Bandrés‐Ciga, S., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00288-w · Cited by 194
Self-citation
The Patterns of Inheritance in Early-Onset Dementia
Jarmolowicz, A. I., Chen, H.-Y., & Panegyres, P. K. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514545825 · Cited by 91
Self-citation

See all 168

Authors: Paulsen, J. S., Nance, M., Kim, J.-I., Carlozzi, N. E., Panegyres, P. K., Erwin, C., Goh, A., McCusker, E., & Williams, J. K.
Affiliations: University of Iowa (US)
Park Nicollet Methodist Hospital (US)
University of Michigan (US)
The University of Texas Health Science Center at Houston (US)
The Royal Melbourne Hospital (AU)
The University of Sydney (AU)
Corresponding author: Paulsen, Jane S.
ORCID: Paulsen, Jane S.
Nance, Martha
Carlozzi, Noelle E.
Panegyres, Peter K.
Erwin, Cheryl
Goh, Anita
Williams, Janet K.
Venue: Progress in Neurobiology
Publisher: Elsevier BV
Published: 2013-11
Volume: 110
Pages: 2-28
ISSN: 0301-0082 (ISSN-L)
DOI: 10.1016/j.pneurobio.2013.08.003
PMC: PMC3833259
OpenAlex: W1980542254
Cited by: 168
References: 290
Citations by year: 2026: 8 · 2025: 16 · 2024: 18 · 2023: 10 · 2022: 18 · 2021: 21 · 2020: 10 · 2019: 14 · 2018: 9 · 2017: 14 · 2016: 8 · 2015: 11 · 2014: 10
FWCI: 0.98
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Progress in Neurobiology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Iowa Research Online (The University of Iowa) (submittedVersion)
Funders: National Institutes of Health (UL1TR000442)
U.S. Public Health Service (NGHG003330)
National Human Genome Research Institute (R01HG003330)
National Institute of Neurological Disorders and Stroke (R01NS040068, R01NS077946, NS040068, R01NS054893, NS054893, NS077946)
National Center for Advancing Translational Sciences
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords: health-related quality of life, predictive genetic testing, early diagnosis, neurodegenerative diseases, patient-reported outcomes, Huntington's disease, Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, frontotemporal dementia, amyotrophic lateral sclerosis, prion disease, hereditary ataxia, dentatorubral-pallidoluysian atrophy, Wilson's disease, direct-to-consumer genetic testing, regret, genetic discrimination, stigmatization
MeSH terms: Brain, Genetic Testing, Humans, Quality of Life, Neurodegenerative Diseases, Early Diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks